NASDAQ · Financial Statements

Acorda Therapeutics, Inc. (ACOR) Financial Statements

$0.66 NASDAQ: ACOR Market Cap $821028

Acorda Therapeutics, Inc. most recently reported annual revenue of $118.0M, net profit of $-253.0M, revenue has compounded at -24.2% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20192020202120222023
Revenue$192.0M$153.0M$129.0M$119.0M$118.0M
Operating Profit$15.0M$-87.0M$-77.0M$-42.0M$-23.0M
Net Profit$-273.0M$-100.0M$-104.0M$-66.0M$-253.0M
EPS$-689.42$-246.40$-195.75$-66.90$-203.59
Op Margin7.6%-56.8%-59.9%-35.5%-19.8%

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$800.0M$633.0M$455.0M$396.0M$118.0M
Total Liabilities$489.0M$395.0M$304.0M$302.0M$276.0M
Cash$62.0M$71.0M$46.0M$38.0M$30.0M
Borrowings$250.0M$260.0M$191.0M$173.0M$191.0M

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$-128.0M$-61.0M$-41.0M$-21.0M$-14.0M
Investing Cash Flow$-91.0M$119.0M$148.0M$0$-1.0M
Financing Cash Flow$-61.0M$-2.0M$-70.0M$0$0
Net Cash Flow$-189.0M$-2.0M$-38.0M$-21.0M$-14.0M
Free Cash Flow$-219.0M$-65.0M$-42.0M$-21.0M$-14.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.80
FCF Yield-1735.39%
Quick Ratio0.26
Interest Coverage-0.74
Return 1Y—
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
ACOR Overview ACOR Dividend Run Stock Screener